Atrys Health was founded in 2007, is listed on the Spanish stock market and is present in eight countries in Europe and Latin America. Its field of action is focused on the areas of oncology, diagnosis and precision treatment, as well as occupational health, and it is recognized for its technological innovations in the field of telemedicine and radiotherapy.
Ramírez stated that the sale of Cuidarte will allow significant capitalization for SOHIN, which will be used to underpin the 2023 business plan, which seeks to expand the Genethic Services division, focused on the genetic and genomic diagnosis of diseases.
SOHIN will also focus on the technological strengthening of the Concierge model, the support service for patients and caregivers with chronic degenerative diseases that today benefits more than 25,000 patients monthly; as well as the growth of the group’s participation in private occupational and preventive health programs.